Adaptive Biotechnologies
ADPT
#6544
Rank
A$1.27 B
Marketcap
A$31.95
Share price
6.86%
Change (1 day)
62.83%
Change (1 year)

Market capitalization of Adaptive Biotechnologies (ADPT)

Market cap: A$1.27 Billion

As of August 2026 Adaptive Biotechnologies has a market cap of A$1.27 Billion. This makes Adaptive Biotechnologies the world's 6544th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Adaptive Biotechnologies from 2019 to 2026

End of year Market Cap

Year Marketcap Change
2026A$1.27 B-66.42%
2025A$3.80 B155.05%
2024A$1.49 B43.33%
2023A$1.04 B-35.15%
2022A$1.60 B-70.61%
2021A$5.46 B-48.06%
2020A$10.51 B96.52%
2019A$5.35 B

End of Day market cap according to different sources

On Aug 30th, 2026 the market cap of Adaptive Biotechnologies was reported to be:

A$5.60 Billion
by Nasdaq info icon info icon
A$1.27 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
HCA Healthcare
HCA
A$126.18 B 9,770.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Premier
PINC
A$3.26 B 155.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Community Health Systems
CYH
A$0.57 B-55.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Select Medical Holdings
SEM
A$2.85 B 123.33%๐Ÿ‡บ๐Ÿ‡ธ USA